Cookson Peirce & Co. Inc. purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 7,986 shares of the semiconductor company’s stock, valued at approximately $3,751,000.
A number of other institutional investors have also recently made changes to their positions in the company. Havemeyer Place LP purchased a new position in shares of Synopsys during the 4th quarter valued at $2,721,000. 111 Capital purchased a new stake in Synopsys during the 4th quarter worth about $1,590,000. MCF Advisors LLC lifted its holdings in Synopsys by 17.8% during the 4th quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company’s stock worth $81,000 after purchasing an additional 26 shares in the last quarter. Pinebridge Investments LLC purchased a new stake in Synopsys during the 4th quarter worth about $121,583,000. Finally, PBU The Pension Fund of Early Childhood & Youth Educators purchased a new stake in Synopsys during the 4th quarter worth about $17,908,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Price Performance
Shares of NASDAQ SNPS opened at $464.85 on Friday. The firm has a market capitalization of $89.01 billion, a P/E ratio of 107.60, a P/E/G ratio of 2.83 and a beta of 1.22. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock’s 50-day simple moving average is $466.55 and its two-hundred day simple moving average is $457.80. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73.
Analyst Ratings Changes
SNPS has been the topic of a number of recent research reports. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the stock a “buy” rating in a report on Wednesday, February 25th. Citigroup increased their price objective on Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Rosenblatt Securities increased their price objective on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday, May 26th. Morgan Stanley increased their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. Finally, HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective on the stock. in a report on Friday, February 20th. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Synopsys presently has an average rating of “Hold” and a consensus price target of $563.81.
Check Out Our Latest Stock Report on Synopsys
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
- Five stocks we like better than Synopsys
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
